Forte Biosciences, Inc. FBRX
Institutional shares held
19 Million
1K
calls
0
puts
Total value of holdings
$12M
$0
calls
$0
puts
Market Cap
$12.8M
20,340,300
Shares Out.
Institutional ownership
93.65%
# of Institutions
34
We take great care to ensure that the data presented and summarized in this overview for Forte Biosciences, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding FBRX
View all-
Tybourne Capital Management (Hk) LTD Hong Kong, K33.62MShares$2.28 Million0.57% of portfolio
-
Perceptive Advisors LLC New York, NY3.27MShares$2.06 Million0.05% of portfolio
-
Bvf Inc San Francisco, CA2.98MShares$1.88 Million0.06% of portfolio
-
Cable Car Capital LLC San Francisco, CA2.03MShares$1.28 Million1.95% of portfolio
-
Fred Alger Management, LLC New York, NY1.84MShares$1.16 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA1.81MShares$1.14 Million0.01% of portfolio
-
Bml Capital Management, LLC Zionsville, IN1.76MShares$1.11 Million0.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA665KShares$419,0940.0% of portfolio
-
Geode Capital Management, LLC Boston, MA343KShares$216,3620.0% of portfolio
-
Black Rock Inc. New York, NY175KShares$110,1600.0% of portfolio
Latest Institutional Activity in FBRX
Top Purchases
Top Sells
About FBRX
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
Insider Transactions at FBRX
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 01
2024
|
Paul A. Wagner |
SELL
Payment of exercise price or tax liability
|
Direct |
2,453
-0.13%
|
$0
$0.71 P/Share
|
|
Apr 01
2024
|
Paul A. Wagner |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+1.63%
|
-
|
|
Apr 01
2024
|
Antony A Riley CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,345
-1.69%
|
$0
$0.71 P/Share
|
|
Apr 01
2024
|
Antony A Riley CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
9,375
+4.52%
|
-
|
|
Jan 01
2024
|
Paul A. Wagner |
SELL
Payment of exercise price or tax liability
|
Direct |
4,109
-0.22%
|
$0
$0.82 P/Share
|
|
Jan 01
2024
|
Paul A. Wagner |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+1.66%
|
-
|
|
Jan 01
2024
|
Antony A Riley CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,841
-2.0%
|
$0
$0.82 P/Share
|
|
Jan 01
2024
|
Antony A Riley CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
9,375
+4.65%
|
-
|
|
Jan 01
2024
|
Hubert C Chen Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,073
-3.19%
|
$0
$0.82 P/Share
|
|
Jan 01
2024
|
Hubert C Chen Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+7.21%
|
-
|
|
Dec 18
2023
|
Paul A. Wagner |
BUY
Open market or private purchase
|
Direct |
10,000
+0.55%
|
$0
$0.75 P/Share
|
|
Dec 14
2023
|
Paul A. Wagner |
BUY
Open market or private purchase
|
Direct |
10,000
+0.55%
|
$0
$0.72 P/Share
|
|
Dec 13
2023
|
Paul A. Wagner |
BUY
Open market or private purchase
|
Direct |
10,520
+0.58%
|
$0
$0.7 P/Share
|
|
Dec 12
2023
|
Paul A. Wagner |
BUY
Open market or private purchase
|
Direct |
4,776
+0.27%
|
$0
$0.65 P/Share
|
|
Dec 11
2023
|
Paul A. Wagner |
BUY
Open market or private purchase
|
Direct |
25,000
+1.38%
|
$0
$0.65 P/Share
|
|
Dec 08
2023
|
Paul A. Wagner |
BUY
Open market or private purchase
|
Direct |
15,000
+0.84%
|
$0
$0.62 P/Share
|
|
Dec 07
2023
|
Paul A. Wagner |
BUY
Open market or private purchase
|
Direct |
36,203
+2.03%
|
$0
$0.58 P/Share
|
|
Nov 22
2023
|
Paul A. Wagner |
BUY
Open market or private purchase
|
Direct |
400
+0.02%
|
$0
$0.43 P/Share
|
|
Nov 20
2023
|
Paul A. Wagner |
BUY
Open market or private purchase
|
Direct |
6,966
+0.14%
|
$0
$0.43 P/Share
|
|
Oct 01
2023
|
Paul A. Wagner |
SELL
Payment of exercise price or tax liability
|
Direct |
2,453
-0.14%
|
$0
$0.66 P/Share
|
Last 12 Months Summary
Buy / Acquisition
1.08M
Shares
From
10
Insiders
| Grant, award, or other acquisition | 777K shares |
|---|---|
| Exercise of conversion of derivative security | 185K shares |
| Open market or private purchase | 119K shares |
Sell / Disposition
33.4K
Shares
From
3
Insiders
| Payment of exercise price or tax liability | 33.4K shares |
|---|